Literature DB >> 18852419

Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study.

Gerald Liew1, A Richey Sharrett, Jie Jin Wang, Ronald Klein, Barbara E K Klein, Paul Mitchell, Tien Y Wong.   

Abstract

OBJECTIVE: To examine the relative contributions of systemic cardiovascular factors to retinal arteriolar and venular caliber in men and women and in whites and African Americans.
METHODS: In the Atherosclerosis Risk in Communities study, retinal arteriolar caliber (central retinal arteriolar equivalent), and venular caliber (central retinal venular equivalent) were measured from digitized retinal photographs of 8794 participants.
RESULTS: The main systemic determinants of narrower central retinal arteriolar equivalent were, in order of relative decreasing contribution, higher current mean arterial blood pressure, lower serum albumin level, current alcohol consumption, and higher body mass index (calculated as weight in kilograms divided by height in meters squared). The main systemic determinants of wider central retinal venular equivalent were current cigarette smoking and higher current mean arterial blood pressure, followed by higher white blood cell count, body mass index, and plasma low-density lipoprotein cholesterol levels. These associations were generally similar in whites and African Americans and in men and women.
CONCLUSIONS: The major systemic determinant of narrower retinal arteriolar caliber is higher blood pressure, while those of wider retinal venular caliber are cigarette smoking, higher blood pressure, systemic inflammation, and obesity. These data offer further insights into the systemic processes influencing arteriolar and venular characteristics and may help explain the observed associations of retinal vascular caliber and the risk of clinical cardiovascular disease.

Entities:  

Mesh:

Year:  2008        PMID: 18852419      PMCID: PMC2995700          DOI: 10.1001/archopht.126.10.1404

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  45 in total

1.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

Authors:  L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

2.  Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  J J Nelson; D Liao; A R Sharrett; A R Folsom; L E Chambless; E Shahar; M Szklo; J Eckfeldt; G Heiss
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

3.  Retinal vessel diameters and the role of inflammation in cerebrovascular disease.

Authors:  Frank Jan de Jong; M Kamran Ikram; Jacqueline C M Witteman; Albert Hofman; Paulus T V M de Jong; Monique M B Breteler
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

4.  Long-term effects of smoking on retinal microvascular caliber.

Authors:  Annette Kifley; Gerald Liew; Jie Jin Wang; Shweta Kaushik; Wayne Smith; Tien Y Wong; Paul Mitchell
Journal:  Am J Epidemiol       Date:  2007-10-12       Impact factor: 4.897

5.  Plasma asymmetric dimethylarginine and retinal vessel diameters in middle-aged men.

Authors:  Virpi Hemminki; Juha Laakso; Mika Kähönen; Väinö Turjanmaa; Hannu Uusitalo; Terho Lehtimäki; Inkeri Ruokonen; Reijo Laaksonen; Heini Huhtala; Hannu Päivä
Journal:  Metabolism       Date:  2007-10       Impact factor: 8.694

Review 6.  The eye in hypertension.

Authors:  Tien Yin Wong; Tien Wong; Paul Mitchell
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

7.  Effects of estrogen on cerebral blood flow and pial microvasculature in rabbits.

Authors:  M T Littleton-Kearney; D M Agnew; R J Traystman; P D Hurn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-09       Impact factor: 4.733

8.  Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study.

Authors:  R Klein; A R Sharrett; B E Klein; L E Chambless; L S Cooper; L D Hubbard; G Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

9.  Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study.

Authors:  Frank Jan de Jong; Meike W Vernooij; M Kamran Ikram; M Arfan Ikram; Albert Hofman; Gabriel P Krestin; Aad van der Lugt; Paulus T V M de Jong; Monique M B Breteler
Journal:  Ophthalmology       Date:  2007-12-11       Impact factor: 12.079

10.  Body mass index and its effects on retinal vessel diameter in 6-year-old children.

Authors:  B Taylor; E Rochtchina; J J Wang; T Y Wong; S Heikal; S M Saw; P Mitchell
Journal:  Int J Obes (Lond)       Date:  2007-07-03       Impact factor: 5.095

View more
  44 in total

1.  Retinal microvascular changes and the risk of developing obesity: population-based cohort study.

Authors:  Anoop Shankar; Charumathi Sabanayagam; Barbara E K Klein; Ronald Klein
Journal:  Microcirculation       Date:  2011-11       Impact factor: 2.628

2.  Comparison of subjective and objective methods to determine the retinal arterio-venous ratio using fundus photography.

Authors:  Rebekka Heitmar; Angelos A Kalitzeos; Sunni R Patel; Diana Prabhu-Das; Robert P Cubbidge
Journal:  J Optom       Date:  2014-07-26

3.  Retinal vascular caliber and risk of dementia: the Rotterdam study.

Authors:  F J de Jong; E M C Schrijvers; M K Ikram; P J Koudstaal; P T V M de Jong; A Hofman; J R Vingerling; M M B Breteler
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

4.  Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals.

Authors:  Manja Reimann; Walthard Vilser; Matthias Gruber; Stefan R Bornstein; Tjalf Ziemssen
Journal:  Diabetologia       Date:  2015-05-24       Impact factor: 10.122

5.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

6.  Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study.

Authors:  Hiroshi Yatsuya; Aaron R Folsom; Tien Y Wong; Ronald Klein; Barbara E K Klein; A Richey Sharrett
Journal:  Stroke       Date:  2010-06-03       Impact factor: 7.914

7.  Usefulness of the second derivative of the finger photoplethysmogram for assessment of end-organ damage: the J-SHIPP study.

Authors:  Yasuharu Tabara; Michiya Igase; Yoko Okada; Tokihisa Nagai; Tetsuro Miki; Yasumasa Ohyagi; Fumihiko Matsuda; Katsuhiko Kohara
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

8.  Admixture mapping scans identify a locus affecting retinal vascular caliber in hypertensive African Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ching-Yu Cheng; David Reich; Tien Y Wong; Ronald Klein; Barbara E K Klein; Nick Patterson; Arti Tandon; Man Li; Eric Boerwinkle; A Richey Sharrett; W H Linda Kao
Journal:  PLoS Genet       Date:  2010-04-15       Impact factor: 5.917

9.  Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA).

Authors:  Sara D Adar; Ronald Klein; Barbara E K Klein; Adam A Szpiro; Mary Frances Cotch; Tien Y Wong; Marie S O'Neill; Sandi Shrager; R Graham Barr; David S Siscovick; Martha L Daviglus; Paul D Sampson; Joel D Kaufman
Journal:  PLoS Med       Date:  2010-11-30       Impact factor: 11.069

10.  Vasoconstriction and Impairment of Neurovascular Coupling after Subarachnoid Hemorrhage: a Descriptive Analysis of Retinal Changes.

Authors:  Catharina Conzen; Walid Albanna; Miriam Weiss; David Kürten; Walthard Vilser; Konstantin Kotliar; Charlotte Zäske; Hans Clusmann; Gerrit Alexander Schubert
Journal:  Transl Stroke Res       Date:  2017-11-08       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.